Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Clinical-trials-phase-iii crawled date : 2021 - 05 - 06 save search
Galmed Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Business Update on Thursday May 13
Published: 2021-05-06 (Crawled : 14:15) - biospace.com/
GLMD | $0.3614 4.2K
|
Health Technology
|
| O: 0.16%
H: 1.6%
C: -15.06%
financial results results
Summit Therapeutics Publishes Scientific Updates to Corporate Website
Published: 2021-05-06 (Crawled : 14:15) - biospace.com/
SMMT | $3.67 -1.61% 83K
|
Health Technology
|
| O: 0.49%
H: 1.14%
C: -3.25%
therapeutics
New Analysis of UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) Published in Neurology Neuroimmunology & Neuroinflammation
Published: 2021-05-06 (Crawled : 14:15) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -1.78%
H: 2.55%
C: 2.48%
immunology
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
RCAT | $1.52 26.67% 1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.